Trends and Predictors of Premature Termination of Cardiovascular Trials

20260 citationsJournal Articlediamond Open Access

Authors

Frederick Berro Rivera · Mayo Clinic

Nathan Ross B. Bantayan

J V Magalong · San Beda University

Chieh-Mei Tsai · Mayo Clinic

Nicole Ann Tesoro · New York City Health and Hospitals Corporation

Polyn Luz S Pine · Ateneo de Manila University

Neill Steven Cainglet Cachuela · University of Santo Tomas

Abstract

More than 1 in 10 cardiovascular trials terminate early, most often due to poor recruitment, which is frequently under-reported. Improved feasibility assessment and transparent reporting are needed. (Trends and Predictors of Premature Termination of Cardiovascular Trials: A Systematic Review; CRD420251155096).

Topics & Keywords

Ethics in Clinical Research Lipoproteins and Cardiovascular Health Statistical Methods in Clinical Trials

Publication Details

Published in: JACC Advances

DOI: 10.1016/j.jacadv.2026.102606

Field-Weighted Citation Impact: 0.00

Command Palette

Trends and Predictors of Premature Termination of Cardiovascular Trials

Authors

Abstract

Topics & Keywords

Publication Details